ACM Research raises 2023 revenue outlook to $530-545M; guides 2024 revenue $650-725M

ACM Research, Inc.

2023-FY EPS reported $1.16 revenue$557,723,000

2023 revenue outlook raised to $530-545M from prior $520-540M, citing strong China demand.
Initial 2024 revenue guidance of $650-725M, driven by mature node investments and multi-product expansion.
CEO David Wang highlights progress with customers beyond mainland China for future growth.
Full year 2023 financial results expected in late February 2024.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

ACM Research, Inc. reported full year 2024 results: revenue $650 million to $725 million. Guidance initiated.

Period: full year 2024
Revenue: $650 million to $725 million
Guidance: initiated
Result: guidance update

Exact text from the filing

ACM also announced that it expects revenue for the full year 2024 to be in the range of $650 million to $725 million.

View on SEC.gov

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

ACM Research, Inc. reported full year 2023 results: revenue $530 million to $545 million. Guidance raised.

Period: full year 2023
Revenue: $530 million to $545 million
Guidance: raised
Result: preliminary results

Exact text from the filing

ACM Research, Inc. (“ACM”) (NASDAQ: ACMR), a leading supplier of wafer processing solutions for semiconductor and advanced wafer-level packaging applications, today has updated its full year 2023 revenue outlook to a range of $530 million to $545 million, versus a range of $520 million to $540 million as was provided in ACM’s third quarter 2023 earnings release issued on November 7, 2023.

View on SEC.gov

Browse all earnings releases →

ACM Research, Inc. filing history →

Source: SEC EDGAR

accession 0001140361-24-001418

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.